US Patent 8008452 Phosphorylated Ndr kinase
Patent 8008452 was granted and assigned to Novartis on August, 2011 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 8008452 Phosphorylated Ndr kinase
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
